THE Cannabis Picks In 2022 | Trade To Black Podcast
THE Cannabis Picks In 2022 | Trade To Black Podcast
In this week’s Trade To Black Podcast, we again speak with Benjamin A. Smith with Anthony Varrell about the sectors that we cover. We focus on U.S. cannabis: with the hope of federal legislative action discounted in the near term, the focus shifts towards 2022 has commenced. It’s a tricky investing environment, with AdvisorShares Pure US Cannabis ETF (MSOS) still searching for bottom to stem the non-stop hemorrhaging that has taken place in 2021. The plurality of market watchers expect a rebound and sentiment remains high, but the headwinds of slower quarter-over-quarter growth and an uncertain regulatory environment remain. This is countered by the fact that Tier-1 MSOS remain very cheap according to growth valuation metrics, and its longer-term prospects look outstanding.
As usual, we also cover the crypto/NFT and psychedelics markets in the aftermath.
__________________________________________________________
Timestamps:
0:00 Intro
Cannabis
1:49 Canada’s largest investment bank, Canaccord Genuity, released their top U.S. cannabis stocks for 2022. We discuss the picks.
4:52 Both Ben and Varrell like Curaleaf Holdings going into 2022.
5:41 Cantor Fitzgerald analyst Pablo Zuanic doesn’t think calendar Q4 2021 growth will be particularly inspiring in U.S. cannabis. We discuss his recent note in detail and provide commentary.
8:47 What happened with MSOS and the industry this past year?
12:20 Investment bank Piper Sandler with lowered 2022 revenue estimates and a steep price target drop on Tilray ($13 higher than $8). We discuss this and the recent Canaccord price target drop on Hexo Corp. ($2 higher than $1) which leads the Canadian market in dry flower market share.
16:48 Ben and Anthony’s bold prediction for U.S. cannabis in 2022.
Psychedelics
19:21 Key atai Life Sciences shareholders announced an extensive share lock-up and the stock price fell ~32%. Bear market doing bear market things. We discuss.
20:38 The psychedelics industry is dominated by retail investors and this needs to change.
23:42 If Big Pharma initiates partnerships with certain psychedelic companies, is this the green light to get investors excited again?
26.15 Big trends for 2022.
Crypto/NFTs
29:03 Nike and Adidas have entered the NFT space. Anthony’s perspective on Big Corp. entering Web 3.0
31:35 A lot of the NFT community is apprehensive about Big Brands entering. Why?
33:05 The early adopters are always vilified.
35:48 What is a bold statement for the NFT market in 2022?
36:39 Does crypto crash in 2022?
38:55 Cryptocurrency are not currencies.
39:30 Finalizing
To watch Trade To Black Podcast #15, click here:
__________________________________________________________
About Channel:
We are a business news platform that provides the latest and best insight on the stories making headlines around the world. We give Institutional and retail investors an inside edge in the competitive world of investing and profile companies that are making waves in their ever-growing industries.
We are The Dales Report.
Check out our website: https://thedalesreport.com/
Subscribe to our channel at https://article.thedalesreport.com/yo…
Connect with us on our social media handles:
Twitter: https://twitter.com/TheDalesReport
Instagram: https://www.instagram.com/thedalesrep…
Tiktok: https://www.tiktok.com/@thedalesrepor…
Facebook: https://www.facebook.com/thedalesreport
TDR Contributors Instagram:
Nicolle Hodges: https://www.instagram.com/nicolledoublel/
Anthony Varrell: https://www.instagram.com/anthonyvarrell/
Amanda Siebert: https://www.instagram.com/amanda_siebert/
_________________________________________________
Guess the price of Bitcoin on 12/31 for a chance to win $1,000 in CASH. Click on the link below for more details 👉🏼 https://bit.ly/3pLFxAY
_________________________________________________
The Dales Report Inc. disclosure policy applies to this video: https://thedalesreport.com/disclosure/
Turning the biomass into Vape oil and other concentrates (significantly longer shelf life and price stability it would appear) are the way they’ve solved the problem.
Verano is a 45 to 50 dollar stock.
Thank you Shadd for correcting Benjamin on Tilray. It’s actually grossly undervalued and is well positioned for legalization in both Germany and the U.S.
I think the wholesale price dropping is going to benefit MSOs because their customer base is accustomed to paying what their paying. IMO, retail prices stay the same, profit margins increase for those not dependent on wholesale revenue.
Curaleaf…. their SELECT brand is pretty much everywhere.
Verano is a $40 stock.
😎
Canada is a bad place to do business, I would never invest in a Canada company.